Tudor Investment Corp
APLS

Tudor Investment Corp’s Apellis Pharmaceuticals APLS Stock Holding History

Tudor Investment Corp’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.1M Buy
650,000
+435,000
+202% +$9.37M 0.05% 320
2025
Q4 		$5.4M Buy
+215,000
New +$5.04M 0.01% 1105
2025
Q2 		– Sell
-52,980
Closed -$1.16M – 3213
2025
Q1 		$1.16M Buy
+52,980
New +$1.46M ﹤0.01% 1720
2024
Q4 		– Sell
-73,002
Closed -$2.2M – 2983
2024
Q3 		$2.11M Buy
+73,002
New +$2.7M 0.01% 1170
2024
Q1 		– Sell
-9,962
Closed -$596K – 2193
2023
Q4 		$596K Sell
9,962
-40,150
-80% -$2.04M ﹤0.01% 1701
2023
Q3 		$1.91M Buy
50,112
+42,714
+577% +$1.88M 0.02% 949
2023
Q2 		$674K Buy
+7,398
New +$638K 0.01% 1543
2022
Q3 		– Sell
-34,707
Closed -$1.57M – 2289
2022
Q2 		$1.57M Sell
34,707
-14,133
-29% -$644K 0.04% 625
2022
Q1 		$2.48M Buy
+48,840
New +$2.16M 0.06% 444
2021
Q4 		– Sell
-150,703
Closed -$4.97M – 2359
2021
Q3 		$4.97M Buy
150,703
+128,065
+566% +$7.2M 0.08% 274
2021
Q2 		$1.43M Buy
+22,638
New +$1.17M 0.03% 703
2021
Q1 		– Sell
-29,448
Closed -$1.68M – 1539
2020
Q4 		$1.68M Buy
29,448
+9,507
+48% +$402K 0.05% 484
2020
Q3 		$602K Buy
+19,941
New +$596K 0.03% 743

Other funds holding APLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Tudor Investment Corp's APLS Position: Q1 2026 in Review

Tudor Investment Corp increased its Apellis Pharmaceuticals (APLS) stake by 202% in Q1 2026, buying an estimated $9.37M and bringing the position to 650,000 shares worth $26.1M. The position accounts for 0.05% of the portfolio, ranked #320.

Tudor Investment Corp first reported a position in APLS in Q3 2020 and has held it in 13 quarters since. 323 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

  • Tudor Investment Corp held 650,000 shares of Apellis Pharmaceuticals worth $26.1M as of Q1 2026.
  • Tudor Investment Corp bought 435,000 Apellis Pharmaceuticals shares in Q1 2026, an estimated $9.37M.
  • Apellis Pharmaceuticals made up 0.05% of Tudor Investment Corp's portfolio in Q1 2026, its #320 holding.
  • Tudor Investment Corp first reported a position in Apellis Pharmaceuticals in Q3 2020 and has held it in 13 quarters since.
  • 323 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.